You are here: Industry Insights > Pall

News List

Project worth £3.1mn to develop advanced controls for biopharma manufacturing europeanpharmaceuticalreview
August 02, 2021
A collaborative project will develop automated manufacturing controls for biologics such as antibodies, viral vectors and vaccines.
Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions prnasia
July 27, 2021
An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher Corporation, will expand manufacturing capacity and services across geographies for global life sciences customers.
Pall, Servier Enter Biomanufacturing Tie-up contractpharma
July 22, 2019
Pall chosen as single-source supplier for Servier’s purpose built end-to-end biomanufacturing facility in Gidy, France.
Pall, and G-CON Manufacturing Announce Collaboration americanpharmaceuticalreview
September 28, 2018
G-CON Manufacturing and Pall are collaborating to bring turnkey continuous bioprocess or viral vector production facility solutions to the industry. G-CON PODs will be customized with advanced Pall Biotech bioprocess equipment, including automation and ut
Pall, Aetos Biologics Announce Biosimilar Manufacturing Partnership americanpharmaceuticalreview
September 14, 2018
Pall Corporation has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development company.
Pall, Celltheon form Partnership for Biotherapeutics Development and Manufacturing americanpharmaceuticalreview
September 05, 2018
Pall Corporation has formed a strategic partnership with Celltheon Corporation, an experienced cell line and expression technology platform development company.
Pall Corporation introduces proprietary bioreactor control system biospectrumasia
August 01, 2017
The mPath benchtop bioreactor control system is a first-of-its-kind solution to deliver accurate measurement and control of single-use process development-scale bioprocesses.
LonzaNEWS Pall Corporation Introduces Proprietary Bioreactor Control System europeanpharmaceuticalreview
July 28, 2017
Pall Corporation, a leader in filtration, separation and purification, is pleased to introduce the mPath™ bioreactor control system to the biopharmaceutical market…